The global microbial identification market is anticipated to grow at a significant CAGR of 10.5% during the forecast period (2024-2031). Ongoing demand to improve the effectiveness, accuracy and speed of microbiological identification has promoted laboratories and healthcare facilities to embrace automated systems and cutting-edge technologies such as genomics, artificial intelligence (AI), and molecular diagnostics. By incorporating cutting-edge technologies, medical professionals and researchers can enhance patient outcomes, make wise decisions, and obtain insightful knowledge. The requirement for quick and precise identification techniques is what's driving this development, particularly in light of the need for tailored medication, antibiotic resistance, and newly developing infectious diseases. To cater the market demand key players are adopting different strategic moves. For instance, in February 2024, bioMérieux S.A. has entered into strategic research collaboration with the US FDA, Center for Food Safety and Applied Nutrition (CFSAN), Offices of Applied Research and Safety Assessment (OARSA) and Regulatory Science (ORS) to develop tools to combat food-borne pathogens. The agreement will pave the way for many innovative projects to improve detection and microbial characterization systems for pathogens that pose a risk in foods.
Browse the full report description of “Microbial Identification Market Size, Share & Trends Analysis Report by Product & Service (Instrument, Consumables, Software & Services), by Technology (Mass Spectrometry, PCR, Microarrays, and Next Generation Sequencing) by Method (Phenotypic Methods, Genotypic Methods, and Proteotypic Methods), by Application (Clinical Diagnostics, Pharmaceuticals, Food & Beverage Testing, and Environmental Application) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/microbial-identification-market
Further, in November 2023, Qiagen announced the launch of the Microbiome WGS SeqSets, a comprehensive Sample to understand workflow designed to provide an easy-to-use solution that maximizes efficiency and reproducibility in microbiome research.The workflow streamlines the process steps involving sample extraction and next-generation sequencing (NGS) library preparation to prepare the sample for processing in an NGS sequencer, followed by user friendly bioinformatics analysis designed for researchers without expertise in the field.
Furthermore, in March 2022, Accelerate Diagnostics announced thelaunch of Accelerate Arc Module and BC Kit. It is an automated path to rapid and accurate microbial identification for positive blood cultures. Accelerate Arc Module provides application of inline centrifugal and sample preparation techniques,and a suspension of cleaned and concentrated microbial cells, which allows direct transfer to a MALDI spotting plate.
Market Coverage
• The market number available for – 2023-2031
• Base year- 2023
• Forecast period- 2024-2031
• Segment Covered-
o By Products & Services
o By Technology
o By Method
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes Biomérieux SA, Thermo Fisher Scientific Inc, Bruker Corp., Beckman Coulter Inc., Qiagen N.V. and Charles River Laboratories among others.
Key questions addressed by the report.
Global Microbial Identification Market Report Segment
By Products& Services
By Technology
By Method
By Application
Global Microbial Identification Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/microbial-identification-market